-
Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money
The US Internal Revenue Code has numerous regulations which must be adhered to in order […]
-
Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals
Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with […]
-
Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech
Continuing a trend that began in 2017, this year has seen the rise of big […]
-
Whitepaper: Focus on the Antibiotics Market
The antibiotics market is expected to reach USD 57.0 billion by 2024. Rising prevalence of […]
Category: Whitepapers
Archive
Categories
- Let’s Interview Series (51)
- News (42)
- Other Documents (12)
- Presentations (99)
- Reports and analyses (52)
- Whitepapers (4)
- Interviews with leading Life Sciences companies: J-Pharma
- Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory
- Interviews with leading Life Sciences companies: Aipore
- Interviews with leading Life Sciences companies: Varinos Inc.
- The World’s First Drug Discovery Platform Using Quantum Computing – POLARISqb
Category Tags
409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd
